-
Je něco špatně v tomto záznamu ?
Neurosteroids as Selective Inhibitors of Glycine Receptor Activity: Structure-Activity Relationship Study on Endogenous Androstanes and Androstenes
JV. Bukanova, EI. Solntseva, E. Kudova,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2008-03-28
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
32265652
DOI
10.3389/fnmol.2020.00044
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
The ability of androstane and androstene neurosteroids with modifications at C-17, C-5, and C-3 (compounds 1-9) to influence the functional activity of inhibitory glycine and γ-aminobutyric acid (GABA) receptors was estimated. The glycine- and GABA-induced chloride current (IGly and IGABA) were measured in isolated pyramidal neurons of the rat hippocampus and isolated rat cerebellar Purkinje cells, correspondingly, using the patch-clamp technique. Our results demonstrate that all the nine neurosteroids display similar biological activity, namely, they strongly inhibited IGly and weakly inhibited IGABA. The threshold concentration of neurosteroids inducing effects on IGly was 0.1 μM, and for effects on IGABA was 10-50 μM. Moreover, our compounds accelerated desensitization of the IGly with the IC50 values varying from 0.12 to 0.49 μM and decreased the peak amplitude with IC50 values varying from 16 to 22 μM. Interestingly, our study revealed that only compounds 4 (epiandrosterone) and 8 (dehydroepiandrosterone) were able to cause a significant change in IGABA in 10 μM concentration. Moreover, compounds 3 (testosterone), 5 (epitestosterone), 6 (dihydroandrostenedione), and 9 (etiocholanedione) did not modulate IGABA up to the concentration of 50 μM. Thus, we conclude that compounds 3, 5, 6, and 9 may be identified as selective modulators of IGly. Our results offer new avenues of investigation in the field of drug-like selective modulators of IGly.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019430
- 003
- CZ-PrNML
- 005
- 20201123123327.0
- 007
- ta
- 008
- 201103s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fnmol.2020.00044 $2 doi
- 035 __
- $a (PubMed)32265652
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bukanova, Julia V $u Research Center of Neurology, Moscow, Russia.
- 245 10
- $a Neurosteroids as Selective Inhibitors of Glycine Receptor Activity: Structure-Activity Relationship Study on Endogenous Androstanes and Androstenes / $c JV. Bukanova, EI. Solntseva, E. Kudova,
- 520 9_
- $a The ability of androstane and androstene neurosteroids with modifications at C-17, C-5, and C-3 (compounds 1-9) to influence the functional activity of inhibitory glycine and γ-aminobutyric acid (GABA) receptors was estimated. The glycine- and GABA-induced chloride current (IGly and IGABA) were measured in isolated pyramidal neurons of the rat hippocampus and isolated rat cerebellar Purkinje cells, correspondingly, using the patch-clamp technique. Our results demonstrate that all the nine neurosteroids display similar biological activity, namely, they strongly inhibited IGly and weakly inhibited IGABA. The threshold concentration of neurosteroids inducing effects on IGly was 0.1 μM, and for effects on IGABA was 10-50 μM. Moreover, our compounds accelerated desensitization of the IGly with the IC50 values varying from 0.12 to 0.49 μM and decreased the peak amplitude with IC50 values varying from 16 to 22 μM. Interestingly, our study revealed that only compounds 4 (epiandrosterone) and 8 (dehydroepiandrosterone) were able to cause a significant change in IGABA in 10 μM concentration. Moreover, compounds 3 (testosterone), 5 (epitestosterone), 6 (dihydroandrostenedione), and 9 (etiocholanedione) did not modulate IGABA up to the concentration of 50 μM. Thus, we conclude that compounds 3, 5, 6, and 9 may be identified as selective modulators of IGly. Our results offer new avenues of investigation in the field of drug-like selective modulators of IGly.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Solntseva, Elena I $u Research Center of Neurology, Moscow, Russia.
- 700 1_
- $a Kudova, Eva $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czechia.
- 773 0_
- $w MED00163316 $t Frontiers in molecular neuroscience $x 1662-5099 $g Roč. 13, č. - (2020), s. 44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32265652 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20201123123326 $b ABA008
- 999 __
- $a ind $b bmc $g 1586207 $s 1109628
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 13 $c - $d 44 $e 20200320 $i 1662-5099 $m Frontiers in molecular neuroscience $n Front Mol Neurosci $x MED00163316
- LZP __
- $a Pubmed-20201103